MENU

Coronavirus Webinar Series; Understanding Diagnostic Modalities for SARS-CoV-2

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
    Biography
      Jamie obtained her Masters and PhD from the University of Georgia, in Infectious Diseases. During her graduate studies she focused on Coronavirus viral genome annotation and identification of genes associated with pathogenicity. In between her Masters and PhD program she spent time in Ghana aiding the Ministry of Health with developing a vaccine program for women and children. Following her graduate studies, she held a two-year postdoctoral position serving as the primary molecular virologist in a small diagnostic lab, while concurrently serving as an Associate professor of biology at Georgia Gwinnett College (GGC). At GGC she taught a microbiology lab and lecturer. In the diagnostic lab she utilized primary virus isolation, serum neutralization assays, and real time PCR to investigate the origin of outbreaks and the evolution of the pathogens. After her postdoctoral position, she held a brief research associate position at the University of California Davis (UC Davis) where she aided in validating diagnostic assays and looking at the role co-infections play with influenza viruses. She left UC Davis for a small biotech company located in southern California looking to relocate to Eatonton, Ga. In 2014, Jamie joined Aalto Scientific, where she served as the Director of Research. Aalto Scientific is a privately owned manufacturer of control and calibration material for clinical chemistry analyzers. During her time there she oversaw the Research and Development department's relocation serving as the primary source of knowledge transfer for all open design control projects. Due to the relocation, she was able to hire an entire R&D team that was successful in transferring more than five projects to production and two of these projects receiving FDA 510K clearance. This position enabled her to obtain a broad knowledge of clinical chemistry lab analyzers and point of care test (POC). During her time at Aalto she also enjoyed giving back by giving industry guest lectures for the BioChemical Engineering Program at UGA. In 2017, Jamie joined Roche Diagnostics in their Medical and Scientific Affairs Division in Fishers, Indiana supporting their molecular POC devices. In this current role she oversees the Medical Plan and investigator initiated studies associated with the cobas Liat, a CLIA waived molecular POC device. Additionally, she currently serves as a subject matter expert for respiratory pathogens and antimicrobial stewardship initiatives.Starting in early January, Jamie joined Roche's Emergency Response team and has been playing an integral role, from a scientific perspective, on the launch of Roche's SARS-CoV-2 diagnostics assays.

    Abstract

    Staying informed on diagnostic tools for SARS-CoV-2 can be challenging.  Because the results of the various test have different clinical implications it is important to understand the design and intended use of the available test. At the end of the session, the participant will be able to:

    Learning Objectives:

    1. Describe the diagnostic tools available for healthcare providers for SARS-CoV-2

    2. Explain how diagnostics will aid with identifying infections and surveillance

    3. Understand the difference between a molecular assay, an antigen assay, and serology test.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 20, 2021 11:00 AM PDT
    C.E. CREDITS
    APR 20, 2021 11:00 AM PDT
    Date: April 20, 2021 Time: 11:00am (PST), 2:00pm (EST) Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    Loading Comments...
    Show Resources
    Attendees
    • See more